Bifosa 35 Tablet
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Alendronic Acid (35mg)
Overview Bifosa 35 Tablet
OsteoPro 35 tablets are indicated for the prevention and treatment of bone loss (osteoporosis) resulting from menopause or steroid use, and for managing Paget's disease. This medication moderates bone turnover, thereby reducing bone resorption. It offers relief from bone pain, lowers fracture risk, and enhances bone mineral density. OsteoPro 35 should be administered on an empty stomach, consistently at equally spaced intervals as directed by your physician. Maintaining a regular daily schedule improves adherence. Continue taking the medication as prescribed, even if symptoms improve; full therapeutic effects may take several days. OsteoPro 35 is one component of a comprehensive treatment plan, potentially including dietary modifications and calcium/vitamin supplementation. Common, typically mild and transient, side effects include headache, musculoskeletal discomfort, upset stomach, heartburn, and diarrhea. Persistent symptoms warrant medical consultation. Serious kidney complications, particularly in patients with pre-existing kidney disease, dehydration, or diuretic use, are possible, as are low blood calcium and jaw/mouth pain. These necessitate immediate medical attention. This medication is contraindicated during breastfeeding. Prior to use, disclose any kidney issues, calcium deficiencies, or other medications, including those for serious infections or osteoporosis, as drug interactions may occur. Regular monitoring of kidney function and mineral levels may be required. Smoking cessation is strongly recommended due to its negative impact on bone density. Excessive alcohol consumption should also be avoided due to its detrimental effect on bone health.
Primary Ingredients of Bifosa 35 Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased. A meaningful input is required to provide a rewritten version.
Uses of Bifosa 35 Tablet
Managing Osteoporosis and Paget's Disease
Major Benefits of Bifosa 35 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Bifosa 35 Tablet on an empty stomach.
Common Side effects of Bifosa 35 Tablet:
- Diarrhea
- Headache
- Heartburn
- Musculoskeletal (bone, muscle or joint) pain
- Indigestion
How to use Bifosa 35 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Bifosa 35 Tablet on an empty stomach.
How Bifosa 35 Tablet works:
Osteoclast activity is inhibited by Bifosa 35 Tablet, a bisphosphonate medication. This action reduces bone breakdown, leading to increased bone strength and a decreased fracture risk.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Bifosa 35 Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
The use of Bifosa 35 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Bifosa 35 Tablet while breastfeeding is likely safe. Studies in humans indicate minimal risk to the infant. However, it's advisable to monitor the infant's blood calcium levels for the first two months of breastfeeding if using this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Bifosa 35 Tablet. While generally not anticipated, Bifosa 35 Tablet may rarely cause dizziness, intense musculoskeletal pain, and ocular pain or inflammation, potentially impacting driving capabilities.
KidneyCAUTION
Patients with severe kidney impairment should use Bifosa 35 Tablets cautiously, potentially requiring a modified dosage. A physician's consultation is advised. Dosage alteration is unnecessary for those with mild to moderate kidney disease.
LiverSAFE IF PRESCRIBED
Use of Bifosa 35 Tablet in patients with liver conditions appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is advised.
What if you forget to take Bifosa 35 Tablet :
Omit any missed Bifosa 35 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Bifosa 35 Tablet
| Label | Value |
|---|---|
| Chemical Category | Bisphosphonate-based compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Actions | Bisphosphonates: Bone Resorption Inhibitors |
3,018 People bought this recently